Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2022

Feb 14, 2022

31041_dirs_2022-02-14_4a855f74-ee20-4fd3-a1b0-d97cb7223aa9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2022-02-10

Reporting Person: Hyde James C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-10 Common Stock A 820 Acquired 14925 Direct
2022-02-10 Common Stock A 2394 Acquired 17319 Direct
2022-02-10 Common Stock F 738 $138.07 Disposed 16581 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-10 Stock Option $138.07 A 2900 Acquired 2032-02-10 Common Stock (2900) Direct

Footnotes

F1: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.

F2: Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.

F3: 738 of the 2394 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.

F4: Options vest 20% Year 1; 40% Year 2; and 40% Year 3.